Advertisement
Novara — A Smarter Way to Access Global Markets
Markets desk·updated through the day

Profit

BCV posts 5% profit growth as new money inflows surge
EquitiesArticle

BCV posts 5% profit growth as new money inflows surge

Swiss cantonal bank's half-year profit rises despite flat net interest income, with CHF 2.4 bln in new client money driving asset growth to CHF 141.8 bln.

Markets Desk · 21 Aug 2026
Swedish cybersecurity firm Clavister posts 63% revenue surge in Q2
EquitiesArticle

Swedish cybersecurity firm Clavister posts 63% revenue surge in Q2

Clavister Holding AB reported a sharp increase in net sales to 89 million Swedish kronor, reversing a prior-year loss as operating profit reached 13 million kronor. The company cited strong order backlog and a growing sales pipeline.

Markets Desk · 21 Aug 2026
Swiss corporate earnings, economic data due next week
EquitiesArticle

Swiss corporate earnings, economic data due next week

First-half results from Swiss firms and key macro releases are scheduled for Aug. 20-27, including UBS-CFA index, Swissmem tech data and SBB H1 outlook.

Markets Desk · 21 Aug 2026
Graubündner Kantonalbank posts record H1 profit as revenue rises 11%
EquitiesArticle

Graubündner Kantonalbank posts record H1 profit as revenue rises 11%

Swiss regional lender reports CHF 137.2 million net income for the first half of 2025, driven by broad-based growth in interest and fee income. CET1 ratio climbs to 20.2%.

Markets Desk · 21 Aug 2026
Siegfried maintains 2026 outlook after 2H gains from U.S., Australia sites
EquitiesArticle

Siegfried maintains 2026 outlook after 2H gains from U.S., Australia sites

Swiss pharma services group posts 2.2% H1 sales growth to 633M CHF; core EBITDA margin rises to 22.4%. Three newly acquired sites expected to add $100M in 2026 revenue.

Markets Desk · 21 Aug 2026
CSL shares rise 3.3% after FY26 results, buyback announced
EquitiesArticle

CSL shares rise 3.3% after FY26 results, buyback announced

Australia’s CSL advanced for a second day as investors digested stronger-than-expected earnings and a A$1.1 billion buyback program. Brokerage firms upgraded price targets following the FY26 results.

Markets Desk · 21 Aug 2026
Super Retail FY26 sales rise to $4.2bn as profit slips on transformation costs
EquitiesArticle

Super Retail FY26 sales rise to $4.2bn as profit slips on transformation costs

Australia’s Super Retail Group posted record annual sales but normalized profit fell 7% as higher transformation costs weighed on margins. Shares surged 15.3% on the update.

Markets Desk · 21 Aug 2026
Sonic Healthcare posts 13% revenue rise but shares drop on FY2026 outlook
EquitiesArticle

Sonic Healthcare posts 13% revenue rise but shares drop on FY2026 outlook

Australia’s largest pathology provider reported A$10.9 billion in revenue for FY2026, up 13% year-over-year, but its stock fell 9.2% after missing earnings expectations and flagging margin pressures in key markets.

Markets Desk · 21 Aug 2026
Brambles FY26 profit hit by U.S. repair constraints, recovery plan outlined
EquitiesArticle

Brambles FY26 profit hit by U.S. repair constraints, recovery plan outlined

Underlying profit rose 4% to $1.49 billion despite $90 million hit from U.S. repair bottlenecks, with a $25 million repair expansion plan set for FY28. Dividend maintained at 46.15 cents per share.

Markets Desk · 21 Aug 2026
Tempus AI jumps 13% on strong earnings, AI platform validation
EquitiesArticle

Tempus AI jumps 13% on strong earnings, AI platform validation

Chicago-based AI precision medicine firm reports first quarterly profit, raises 2026 revenue guidance after PRISM2 validation study and commercial partnership. Stock hits session high of $59.04.

Markets Desk · 20 Aug 2026
Geberit posts strong Q2 2026 results, raises full-year outlook
EquitiesArticle

Geberit posts strong Q2 2026 results, raises full-year outlook

Swiss plumbing supplier reports 5.9% organic sales growth in first half of 2026 despite currency headwinds, with EPS up 7.9% and EBITDA margin steady at 30.9%.

Markets Desk · 20 Aug 2026
BICO shares surge 13% on Q2 2026 margin gains, revenue growth
EquitiesArticle

BICO shares surge 13% on Q2 2026 margin gains, revenue growth

Swedish biotech firm BICO Group reported a 59% gross margin in Q2 2026, up from 44% a year earlier, driving a 13% pre-market stock surge. Adjusted EBITDA margin improved to 6% from negative 2.6%.

Markets Desk · 20 Aug 2026
Geberit shares jump 7.1% on strong first-half sales growth
EquitiesArticle

Geberit shares jump 7.1% on strong first-half sales growth

Swiss plumbing group posts ninth straight quarter of currency-adjusted sales growth, lifts full-year guidance. Shares rise to CHF 564.2.

Markets Desk · 20 Aug 2026
Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook
EquitiesArticle

Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook

Zahnimplantatehersteller Straumann reports 2.3% total revenue growth to CHF 1.38 billion in H1, with organic sales up 7.8%. CEO transition announced as Daniellot steps down after seven years.

Markets Desk · 20 Aug 2026
Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook
EquitiesArticle

Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook

Swiss dairy group Emmi reports stronger-than-expected first-half growth, with revenue up 2.2% to CHF 2.32bn, while maintaining full-year EBIT and net margin guidance.

Markets Desk · 20 Aug 2026
SK Hynix union nears wage deal amid profit-sharing dispute
EquitiesArticle

SK Hynix union nears wage deal amid profit-sharing dispute

South Korean chipmaker’s labor union finalizes preliminary terms for a 10-year operating profit distribution agreement, including a 10% cash payout to workers. Approval from union members remains pending.

Markets Desk · 20 Aug 2026
Breville FY26 sales rise 9.7% on AI efficiency gains, direct markets drive growth
EquitiesArticle

Breville FY26 sales rise 9.7% on AI efficiency gains, direct markets drive growth

Record AUD 1.81 bln revenue reported as coffee and cooking segments post double-digit gains, with AI tools cutting operational time by up to 84%. Shares dip 3.1% on margin pressure.

Markets Desk · 20 Aug 2026
Basilea Pharmaceutica posts 32% profit surge in H1 2026, raises guidance
EquitiesArticle

Basilea Pharmaceutica posts 32% profit surge in H1 2026, raises guidance

Swiss drugmaker reports CHF 27.9 million net profit for the first half, driven by strong Cresemba sales and non-dilutive funding. Full-year outlook upgraded on revenue and profit growth.

Markets Desk · 19 Aug 2026